HA
Schedule 13G filing
HOLD Alapkezelo Zrt. disclosed a 5.2% stake in Protalix BioTherapeutics, Inc. (PLX)
HOLD Alapkezelo Zrt. reported owning 5.2% of Protalix BioTherapeutics, Inc. (PLX) (4,157,791 shares) in a Schedule 13G filed Oct 15, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 15, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.